(Q33762569)

29 July 2017

1 reference

title

Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant (English)

1 reference

29 July 2017

6

Rooney CM

1 reference

29 July 2017

5

Brenner MK

1 reference

29 July 2017

1

Heslop HE

1 reference

29 July 2017

Perez M

2

1 reference

PubMed ID

10540372

29 July 2017

Benaim E

series ordinal

3

1 reference

PubMed ID

10540372

29 July 2017

Rochester R

series ordinal

4

1 reference

29 July 2017

1 January 1999

1 reference

Journal of Clinical Apheresis

29 July 2017

1 reference

29 July 2017

14

1 reference

29 July 2017

3

1 reference

29 July 2017

154-156

1 reference

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Adenovirus infection after pediatric bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

Donor T cells to treat EBV-associated lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%281999%2914%3A3%3C154%3A%3AAID-JCA9%3E3.0.CO%3B2-K

10.1002/(SICI)1098-1101(1999)14:3<154::AID-JCA9>3.0.CO;2-K

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10540372